ALK and lung carcinoma: Finally, chromosomal rearrangements of Alk are detected in 3%–7% of NSCLCs (Soda et al., 2007) and lung cancers displaying Alk rearrangements are highly sensitive to Alk tyrosine kinase inhibition.